CEP290 and ciliopathy: We recently showed that eupatilin can be used as a variant-independent approach for human CEP290-associated ciliopathies in retinal organoids [25], confirming the work of Kim and colleagues who reported a beneficial effect of Eupatilin in rd16 CEP290 mouse model and CEP290null RPE1 cells.